Last updated on October 2017

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation


Brief description of study

To evaluate the safety and efficacy of ruxolitinib compared to Best Available Therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogeneic stem cell transplantation

Clinical Study Identifier: NCT02913261

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Novartis Pharmaceuticals

Novartis Investigative Site
Westmead, Australia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Herston, Australia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Parkville, Australia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Graz, Austria
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Linz, Austria
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Vienna, Austria
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hamilton, ON Canada
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Toronto, ON Canada
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Montreal, QC Canada
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Copenhagen, Denmark
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Angers Cedex 1, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Besancon cedex, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Grenoble, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lille, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lyon Cedex 08, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nantes, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nice cedex 3, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Paris Cedex 10, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Paris, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pessac, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pierre-Benite Cedex, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Vandoeuvre les Nancy cedex, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Mannheim, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Berlin, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Dresden, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Duesseldorf, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Essen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Freiburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hamburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hannover, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leipzig, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Mainz, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muenster, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Tübingen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wiesbaden, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hong Kong, Hong Kong
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Haifa, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Jerusalem, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Petach Tikva, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Tel Aviv, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ancona, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bergamo, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bologna, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Firenze, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Genova, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Milano, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Roma, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Udine, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nagoya-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Fukuoka city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sapporo-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kobe-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nishinomiya-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Isehara-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kyoto-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sendai-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Okayama-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Osaka-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Suita-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bunkyo-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Chuo-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Minato-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Shinjuku-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Seoul, Korea, Republic of
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Oslo, Norway
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Riyadh, Saudi Arabia
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sevilla, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Barcelona, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Majadahonda, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Madrid, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Valencia, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Göteborg, Sweden
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Uppsala, Sweden
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Taichung, Taiwan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Taipei, Taiwan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
London, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Manchester, United Kingdom
  Connect »